 BPTH | Bio-Path Holdings Inc. Company profile
Company profileBio-Path Holdings is a biotechnology company developing targeted DNA therapeutics for blood cancers and solid tumors. The company's lead candidate is prexigebersen (Liposomal Grb2 Antisense), formerly BP1001, for the treatment of acute myeloid leukemia (AML).
Address4710 Bellaire Boulevard Videos about Bio-Path Holdings Inc. | NotesJump to (Finance sites)         ResearchInvestor pagewww.biopathholdings.comIf you are looking for News & events, Press Release, they are available on their Investors Relationssite. Homepage: biopathholdings.comOther stocks            Support this projectIf you want to help pay for server cost or for improving this tool. You can send it via Paypal. Social MediaRecommended Books Buy on Amazon Currency Trading For Dummies is a hands-on, user-friendly guide that explains how the foreign exchange (ForEx) market works and how you can become a part of it. Currency trading has many benefits, but it also has fast-changing financial-trading avenues. ForEx markets are always moving. So how do you keep up? |
